Trial Profile
Eltrombopag for tyrosine kinase therapy associated thrombocytopenia in patients with chronic myeloid leukaemia and myelofibrosis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 09 Sep 2014 New trial record